Preferred Label : Thalidomide embryopathy;
ICD-11 definition : Thalidomide embryopathy is a group of anomalies presented in an infant as a result
of in utero exposure to thalidomide four to six weeks after conception and is associated
with severe limb reduction defects represented mainly by phocomelia, i.e. absence
of intercalary parts of limbs (humerus and/or forearm, femur and/or lower leg) and
presence of normal or abnormal distal parts (fingers/hands or toes/feet).;
Origin ID : 299085643;
UMLS CUI : C0432365;
Currated CISMeF NLP mapping
- Semantic type(s)
- UMLS correspondences (same concept)
Thalidomide embryopathy is a group of anomalies presented in an infant as a result
of in utero exposure to thalidomide four to six weeks after conception and is associated
with severe limb reduction defects represented mainly by phocomelia, i.e. absence
of intercalary parts of limbs (humerus and/or forearm, femur and/or lower leg) and
presence of normal or abnormal distal parts (fingers/hands or toes/feet).
